Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Up0.80% Nasdaq Up0.97%

Genomic Health Inc. (GHDX)

-NasdaqGS

37.25 Up 0.70(1.92%) May 17, 4:00PM EDT|After Hours : 37.25 0.00 (0.00%) May 17, 4:32PM EDT

Add to Portfolio
ProfileGet Profile for:
Genomic Health Inc.
301 Penobscot Drive
Redwood City, CA 94063-4700
United States - Map
Phone: 650-556-9300
Fax: 650-556-1132
Website: http://www.genomichealth.com

Details 
Index Membership:N/A
Sector:Healthcare
Industry:Medical Laboratories & Research
Full Time Employees:612

Business Summary 

Genomic Health, Inc., a healthcare company, provides actionable genomic information to personalize cancer treatment decisions. It develops and commercializes genomic-based clinical laboratory services that analyze the underlying biology of cancer, allowing physicians and patients to make individualized treatment decisions. The company provides the Oncotype DX invasive breast cancer test that is used for early stage invasive breast cancer patients to predict the likelihood of breast cancer recurrence and the likelihood of chemotherapy benefit. It also offers the Oncotype DX colon cancer test, which is used to predict the likelihood of colon cancer recurrence in patients with stage II disease, as well as for use in patients with stage III disease treated with oxaliplatin-containing adjuvant therapy. In addition, the company provides the Oncotype DX tests for patients with ductal carcinoma in situ, a pre-invasive form of breast cancer. Genomic Health, Inc. was founded in 2000 and is headquartered in Redwood City, California.

Key Statistics


Company Websites 
Home Page
Search Yahoo! for:
More on Genomic Health Inc.

Corporate Governance 
Genomic Health Inc.’s ISS Governance QuickScore as of May 1, 2013 is 5. The pillar scores are Audit: 1; Board: 6; Shareholder Rights: 5; Compensation: 5.
Brought to you by Institutional Shareholder Services (ISS)

Key Executives 
 PayExercised
Ms. Kimberly J. Popovits , 54
Chairman, Chief Exec. Officer, Pres and Member of Non-Management Stock Option Committee
834.00K197.00K
Mr. Dean L. Schorno , 50
Chief Financial Officer and Principal Accounting Officer
446.00K183.00K
Mr. G. Bradley Cole , 57
Chief Operating Officer and Member of Non-Management Stock Option Committee
603.00K882.00K
Ms. Kathy L. Hibbs Esq., 49
Sr. VP, Gen. Counsel and Sec.
432.00K30.00K
Dr. Steven Shak M.D., 62
Chief Medical Officer and Exec. VP of R&D
590.00K0.00
Amounts are as of Dec 30, 2012 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in USD.
View Insiders